Cell therapy strategies for COVID-19: Current approaches and potential applications-Reference-Cited by-同舟云学术

Cell therapy strategies for COVID-19: Current approaches and potential applications

Published:2021-08-13 Issue:33 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Zaki Mark M.¹²^ORCID,Lesha Emal¹³^ORCID,Said Khaled⁴^ORCID,Kiaee Kiavash⁴^ORCID,Robinson-McCarthy Lindsey⁴^ORCID,George Haydy¹,Hanna Angy⁵^ORCID,Appleton Evan⁴⁶,Liu Songlei⁴⁶^ORCID,Ng Alex H. M.¹⁴⁶^ORCID,Khoshakhlagh Parastoo¹⁴⁶^ORCID,Church George M.¹⁴⁶^ORCID

Affiliation:

1. GC Therapeutics Inc., Cambridge, MA 02139, USA.

2. Department of Neurosurgery, University of Michigan, 1500 E Medical Center Dr., Ann Arbor, MI 48109, USA.

3. Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

4. Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

5. Department of Medicine, Beaumont Hospital, Royal Oak, MI, USA.

6. Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, MA 02115, USA.

Abstract

Cell therapy has strong promise for treating COVID-19 survivors due to customizability, targetability, and regenerative function.

Funder

Blavatnik Biomedical Accelerator at Harvard University

Publisher